Stockton, NJ, United States of America

Gary J Grover


 

Average Co-Inventor Count = 1.8

ph-index = 9

Forward Citations = 228(Granted Patents)


Company Filing History:


Years Active: 1989-2005

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: The Innovations of Gary J. Grover: Trailblazer in Pharmaceutical Patents

Introduction

Gary J. Grover, based in Stockton, NJ, is a notable inventor with a prolific career marked by a impressive portfolio of 18 patents. His work primarily focuses on advancements in the pharmaceutical field, particularly in treating serious health conditions. Grover's innovative contributions have significantly impacted the realms of mitochondrial function and cardiac health.

Latest Patents

Among his latest patents is the development of (1-phenyl-2-heteroaryl)ethyl-guanidine compounds. These compounds serve as powerful inhibitors of mitochondrial F1F0 ATP hydrolase and are particularly useful in modulating mitochondrial ATPase activity. This innovation offers potential treatments for ischemic conditions such as myocardial infarction, congestive heart failure, and cardiac arrhythmias. Additionally, Grover has patented a method involving the combination of a potassium channel activator and an antiarrhythmic agent. This method addresses ischemia and arrhythmia in mammals through the simultaneous administration of a potassium channel opener and a class III antiarrhythmic compound, aiming to improve cardiac health outcomes.

Career Highlights

Grover has built a substantial career working with prominent companies in the pharmaceutical industry, including E.R. Squibb & Sons, Inc. and Bristol-Myers Squibb Company. His experiences in these institutions have provided him with the platform and resources to pioneer valuable innovations in drug development and therapeutic strategies.

Collaborations

Throughout his career, Grover has collaborated with esteemed colleagues such as Karnail S. Atwal and James L. Bergey. These collaborations have fostered a productive exchange of ideas and research insights, further enhancing the development of his notable patents.

Conclusion

Gary J. Grover’s contributions to the field of pharmaceuticals are marked by his innovative patents and collaborations with leading industry professionals. His work continues to pave the way for advancements in treatments for critical health conditions, demonstrating his commitment to improving patient outcomes through scientific innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…